Drug development progress in duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD) is a severe, progressive, and incurable X-linked disorder caused by mutations in the dystrophin gene. Patients with DMD have an absence of functional dystrophin protein, which results in chronic damage of muscle fibers during contraction, thus leading to deteriorati...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Jiexin, Zhang, Junshi, Shi, Keli, Liu, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353054/
https://www.ncbi.nlm.nih.gov/pubmed/35935842
http://dx.doi.org/10.3389/fphar.2022.950651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353054/
https://www.ncbi.nlm.nih.gov/pubmed/35935842
http://dx.doi.org/10.3389/fphar.2022.950651

Ejemplares similares